Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

NCT00039130

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 31 locations
View Trial Details
Completed

Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma

NCT01484093

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details
Completed

A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)

NCT03314922

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Aichi Cancer Center Hospital Aichi, Japan
  • National Hospital Organization Kyushu Cancer Center Fukuoka, Japan
  • Cancer Institute Hospital of Jfcr Kōtoku, Japan
  • Nagoya City University Hospital Nagoya, Japan
View Trial Details
Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

NCT00377052

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • QEII Health Sciences Center Halifax, Nova Scotia, Canada
View Trial Details
Completed

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

NCT02343718

Conditions
Central Nervous System, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Children's and Women's Health Centre of BC Branch Vancouver, British Columbia, Canada
  • Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada
  • McMaster Children's Hospital Hamilton, Ontario, Canada
  • Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada
View Trial Details
Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

NCT00030875

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT01399372

Conditions
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
View all 45 locations
View Trial Details

Related conditions